Idiopathic vitreomacular traction and macular hole: A comprehensive review of pathophysiology, diagnosis, and treatment

Eye (Basingstoke)

Volumn 27, Issue SUPPL, 2013, Pages

  Steel, D H W ^a,b   Lotery, A J ^c  

^a SUNDERLAND EYE INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

macular hole; ocriplasmin; posterior vitreous detachment; vitrectomy; vitreomacular traction

Indexed keywords

OCRIPLASMIN; PLACEBO;

BLURRED VISION; CATARACT; CILIARY DISK; CLINICAL FEATURE; CONJUNCTIVAL HEMORRHAGE; DRUG EFFICACY; EYE PAIN; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; METAMORPHOSIS; NONHUMAN; OPTICAL TOMOGRAPHY; PATHOPHYSIOLOGY; QUALITY OF LIFE; RETINA MACULA HOLE; RETINA TEAR; REVIEW; RISK FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL DISORDER; VITREOMACULAR TRACTION; VITREOUS DISEASE;

AGED; DIAGNOSTIC IMAGING; EPIRETINAL MEMBRANE; FIBRINOLYSIN; HUMANS; OPHTHALMIC SOLUTIONS; PATIENT POSITIONING; PEPTIDE FRAGMENTS; RETINAL PERFORATIONS; RISK FACTORS; TISSUE ADHESIONS; TREATMENT OUTCOME; VITRECTOMY; VITREOUS DETACHMENT; WATCHFUL WAITING;

EID: 84885459297     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.212     Document Type: Review

References (167)

1. Sebag J, Balazs EA. Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 1989; 30: 1867-1871. (Pubitemid 19215012)
2. Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc 2005; 103: 537-567. (Pubitemid 43042092)
3. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000; 19: 323-344. (Pubitemid 30122726)
4. Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye 2008; 22: 1214-1222.
5. Ramesh S, Bonshek RE, Bishop PN. Immunolocalisation of opticin in the human eye. Br J Ophthalmol 2004; 88: 697-702. (Pubitemid 38526656)
6. Sebag J. Ageing of the vitreous. Eye 1987; 1: 254-262. (Pubitemid 17126431)
7. Worst JG. Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc UK 1977; 97: 550-554. (Pubitemid 9040475)
8. Itakura H, Kishi S, Li D, Akiyama H. Observation of posterior precortical vitreous pocket using swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 2013; 54: 3102-3107.
9. Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye 1992; 6: 541-552. (Pubitemid 23056653)
10. Foos RY. Vitreoretinal juncture; topographical variations. Invest Ophthalmol 1972; 11: 801-808.
11. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987; 28: 506-514. (Pubitemid 17040860)
12. Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 2001; 119: 1475-1479. (Pubitemid 32963251)
13. American Academy of Ophthalmology. Preferred practice pattern. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration. American Academy of Ophthalmology: San Francisco, CA, USA, 2008.
14. Foos RY, Wheeler NC. Vitreoretinal juncture. Synchisis senilis and posterior vitreous detachment. Ophthalmology 1982; 89: 1502-1512.
15. Hickichi T, Hirokawa H, Kado M, Akiba J, Kakehashi A, Yoshida A et al. Comparison of the prevalence of posterior vitreous detachment in whites and Japanese. Ophthalmic Surg 1995; 26: 39-43.
16. Weber-Krause B, Eckhardt C. Incidence of posterior vitreous detachment in the elderly. Ophthalmologe 1997; 94: 619-623. (Pubitemid 27441487)
17. Chuo JY, Lee TYY, Hollands H, Morris AH, Reyes RC, Rossiter JD et al. Risk factors for posterior vitreous detachment: A case-control study. Am J Ophthalmol 2006; 142: 931-937.
18. Simpson ARH, Petrarca R, Jackson TL. Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol 2012; 57: 498-509.
19. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik Jr JM, Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 2008; 145: 509-517.
20. Yamada N, Kishi S. Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol 2005; 139: 112-117. (Pubitemid 40094847)
21. Spaide RF, Wong D, Fisher Y, Goldbaum M. Correlation of vitreous attachment and foveal deformation in early macular hole states. Am J Ophthalmol 2002; 133: 226-229. (Pubitemid 34072051)
22. Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol 2010; 149: 371-382.
23. Chang LK, Fine HF, Spaide RF, Koizumi H, Grossniklaus HE. Ultrastructural correlation of spectral-domain coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol 2008; 146: 121-127.
24. Foos RY. Vitreoretinal juncture; simple epiretinal membranes. Albrecht v Graefes Arch Klin Exp Ophthalmol 1974; 189: 231-250.
25. Snead DRJ, James S, Snead MP. Pathological changes in the vitreoretinal junction1: epiretinal membrane formation. Eye 2008; 22: 1310-1317.
26. Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 2002; 86: 902-909. (Pubitemid 34827972)
27. Kampik A. Pathology of epiretinal membrane, idiopathic macular hole, and vitreomacular traction syndrome. Retina 2012; 32: S194-S199.
28. Bottos J, Elizalde J, Rodrigues EB, Maia M. Current concepts in vitreomacular traction syndrome. Curr Opin Ophthalmol 2012; 23: 195-201.
29. Hiscott P, Hagan S, Heathcote L, Sheridan CM, Groenewald CP, Grierson I et al. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye 2002; 16: 393-403. (Pubitemid 34845967)
30. Hiscott PS, Grierson I, Trombetta CJ, Rahi AHS, Marshall J, McLeod D. Retinal and epiretinal glia-an immunohistochemical study. Br J Ophthalmol 1984; 68: 698-707. (Pubitemid 15113106)
31. Barak Y, Ihnen MA, Schaal S. Spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal interface pathologies. J Ophthalmol 2012; 1012: 876472.
32. Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson AR et al. Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis. Retina 2013; 33: 1099-1108.
33. Koleva-Georgieva DN, Sivkova NP. Types of diabetic macular edema assessed by optical coherence tomography. Folia Med 2008; 50: 30-38.
34. Ophir A, Trevino A, Fatum S. Extrafoveal vitreous traction associated with diffuse diabetic macular oedema. Eye 2010; 24: 347-353.
35. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand 1999; 77: 170-175. (Pubitemid 29164056)
36. Hickichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes. Ophthalmology 1997; 104: 473-478. (Pubitemid 27120303)
37. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 2005; 139: 638-652.
38. Takahashi A, Yoshida A, Nagaoka T, Takamiya A, Sato E, Kagokawa H et al. Idiopathic full-thickness macular holes and the vitreomacular interface: a high-resolution spectraldomain optical coherence tomography study. Am J Ophthalmol 2012; 154: 881-892.
39. Gass JDM. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988; 106: 629-639.
40. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995; 119: 752-759.
41. Van Newkirk MR, Johnson MW, Hughes JR, Meyer KA, Byrne SF. B-scan ultrasonographic findings in the stages of idiopathic macular hole. Trans Am Ophthalmol Soc 2000; 98: 163-171. (Pubitemid 32059504)
42. Johnson MW, Van Newkirk MR, Meyer KA. Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation. Arch Ophthalmol 2001; 119: 215-222. (Pubitemid 32147928)
43. Smiddy WE, Flynn Jr HW. Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol 2004; 137: 525-537. (Pubitemid 38328645)
44. Gaudric A, Haouchine B, Massin P, Paques M, Blain P, Erginay A. Macular hole formation. New data provided by optical coherence tomography. Arch Ophthalmol 1999; 117: 744-751.
45. Haouchine B, Massin P, Gaudric A. Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology 2001; 108: 15-22. (Pubitemid 32059530)
46. Grigoropoulos VG, Theodossiadis GP, Theodossiadis PG. Association of the preoperative photoreceptor layer defect as assessed by optical coherence tomography with the functional outcome after macular hole closure: a long follow-up study. Ophthalmologica 2011; 225: 47-54.
47. Ezra E, Fariss RN, Possin DE, Aylward WG, Gregor ZJ, Luthert PJ et al. Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol 2001; 119: 223-231. (Pubitemid 32147929)
48. Tornambe PE. Macular hole genesis: the hydration theory. Retina 2003; 23: 421-434.
49. Gentile RC, Landa G, Pons ME, Eliott D, Rosen RB. Macular hole formation, progression, and surgical repair: case series of serial optical coherence tomography and time lapse morphing video study. BMC Ophthalmol 2010; 10: 24.
50. Parolini B, Schumann RG, Cereda MG, Haritoglou C, Pertile G. Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes. Invest Ophthalmol Vis Sci 2011; 52: 9074-9083.
51. Figueroa MS, Noval S, Contreras I. Macular structure on optical coherence tomography after lamellar macular hole surgery and its correlation with visual outcome. Can J Ophthalmol 2011; 46: 491-497.
52. Haouchine B, Massin P, Tadayoni R, Erginay A, Gaudric A. Diagnosis of macular pseudoholes and lamellar macular holes by optical coherence tomography. Am J Ophthalmol 2004; 138: 732-739. (Pubitemid 39452919)
53. Emerson GG, Spencer GR, Klein ML. Macular microholes. Retina 2007; 27: 595-600. (Pubitemid 46905151)
54. Jackson TL, Nicod E, Simpson A, Angelis A, Grimaccia F, Kanavos P. Symptomatic vitreomacular adhesion. Retina 2013; 33: 1503-1511.
55. Chew EY, Sperduto RD, Hiller R, Nowroozi L, Seigel D, Yanuzzi LA et al. Clinical course of macular holes. The Eye Disease Case-Control Study. Arch Ophthalmol 1999; 117: 242-246.
56. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Population based incidence of macular holes. Ophthalmology 2009; 116: 1366-1369.
57. Klein R, Klein BEK. The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc 1994; 92: 403-425.
58. La Cour M, Friis J. Macular holes: classification, epidemiology, natural history, and treatment. Acta Ophthalmol Scand 2002; 80: 579-587. (Pubitemid 36024468)
59. Wang S, Xu L, Jonas JB. Prevalence of full-thickness macular holes in urban and rural adult Chinese: the Beijing Eye Study. Am J Ophthalmol 2006; 141: 589-591. (Pubitemid 43265981)
60. Sen P, Bhargava A, Vijaya L, George R. Prevalence of idiopathic macular hole in adult rural and urban South Indian population. Clin Experiment Ophthalmol 2008; 36: 257-260. (Pubitemid 351565610)
61. Thapa SS, Thapa R, Paudyal I, Khanal S, Aujla J, Paudyal G et al. Prevalence and pattern of vitreo-retinal diseases in Nepal: the Bhaktapur glaucoma study. BMC Ophthalmol 2013; 13: 9.
62. The Eye Disease Case-Control Study Group. Risk factors for idiopathic macular holes. Am J Ophthalmol 1994; 118: 754-761.
63. Coppe AM, Ripandelli G, Parisi V, Varano M, Stirpe M. Prevalence of asymptomatic macular holes in highly myopic eyes. Ophthalmology 2005; 112: 2103-2109. (Pubitemid 41720987)
64. Kumagai K, Ogino N, Hangai M, Larson E. Percentage of fellow eyes that develop full-thickness macular hole in patients with unilateral macular hole. Arch Ophthalmol 2012; 130: 393-394.
65. Knudtson MD, Klein BEK, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 2005; 123: 807-814. (Pubitemid 41056602)
66. Okamoto F, Okamoto Y, Fukuda S, Hiraoka T, Oshika T. Vision-related quality of life and visual function after vitrectomy for various vitreoretinal disorders. Invest Ophthalmol Vis Sci 2010; 51: 744-751.
67. Ezra E. Idiopathic full thickness macular hole: natural history and pathogenesis. Br J Ophthalmol 2001; 85: 102-108. (Pubitemid 32060207)
68. American Academy of Ophthalmology. Preferred Practice Pattern. Idiopathic Macular Hole. American Academy of Ophthalmology: San Francisco, CA, USA, 2008.
69. American Academy of Ophthalmology. Preferred Practice Pattern. Comprehensive Adult Medical Eye Examination. American Academy of Ophthalmology: San Francisco, CA, USA, 2010.
70. Smiddy WE, Gass D. Masquerades of macular holes. Ophthalmic Surg 1995; 26: 16-24.
71. Bottos J, Elizalde J, Arevalo JF, Rodrigues EB, Maia M. Vitreomacular traction syndrome. J Ophthalmic Vis Res 2012; 7: 148-161.
72. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004; 137: 156-169. (Pubitemid 38045202)
73. Kiernan DF, Mieler WF, Hariprasad SM. Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol 2010; 149: 18-31.
74. Barak Y, Sherman MP, Schaal S. Mathematical analysis of specific anatomical foveal configurations predisposing to the formation of macular holes. Invest Ophthalmol Vis Sci 2011; 52: 8266-8270.
75. Kusuhara S, Teraoka Escano MF, Fujii S, Nakanishi Y, Tamura Y, Nagai A et al. Prediction of postoperative visual outcome based on hole configuration by optical coherence tomography in eyes with idiopathic macular holes. Am J Ophthalmol 2004; 138: 709-716. (Pubitemid 39452916)
76. Ruiz-Moreno JM, Staicu C, Piñero DP, Montero J, Lugo F, Amat P. Optical coherence tomography predictive factors for macular hole surgery outcome. Br J Ophthalmol 2008; 92: 640-644. (Pubitemid 351684173)
77. Wakely L, Rahman R, Stephenson J. A comparison of several methods of macular hole measurement using optical coherence tomography, and their value in predicting anatomical and visual outcomes. Br J Ophthalmol 2012; 96: 1003-1007.
78. Xu D, Yuan A, Kaiser PK, Srivastava SK, Singh RP, Sears JE et al. A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci 2013; 54: 163-169.
79. Michalewska Z, Michalewski J, Odrobina D, Nawrocki J. Non-full thickness macular holes reassessed with spectral domain optical coherence tomography. Retina 2012; 32: 922-929.
80. Inoue M, Watanabe Y, Arakawa A, Sato S, Kobayashi S, Kadonosono K. Spectral-domain coherence tomography images of inner/outer segment junctions and macular hole surgery outcomes. Graefes Arch Clin Exp Ophthalmol 2009; 247: 325-330.
81. Salter AB, Folgar FA, Weissbrot J, Wald KJ. Macular hole surgery prognostic success rates based on macular hole size. Ophthalmic Surg Lasers Imaging 2012; 43: 184-189.
82. Hickichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol 1995; 119: 55-61.
83. Weinand F, Jung A, Becker R, Pavlovic S. Spontaneous resolution of vitreomacular traction syndrome. Ophthalmologe 2009; 106: 44-46.
84. Odrobina D, Michalewska Z, Michalewski J, Dziegielewski K, Nawrocki J. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina 2011; 31: 324-331.
85. Hickichi T, Yoshida A, Akiba J, Trempe CL. Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes. Br J Ophthalmol 1995; 79: 517-520.
86. Jonas JB, Decker A, Mangler B, Schlichtenbrede FC. Macular holes and central retinal detachment. Acta Ophthalmol 2011; 89: e377-e378.
87. García-Fernández M, Navarro JC, Sanz AF, Castano CG. Long-term evolution of idiopathic lamellar macular holes and macular pseudoholes. Can J Ophthalmol 2012; 47: 442-447.
88. Bottoni F, Deiro AP, Giani A, Orini C, Cigada M, Staurenghi G. The natural history of lamellar holes: a spectral domain optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol 2013; 251: 467-475.
89. Gaudric A, Aloulou Y, Tadayoni R, Massin P. Macular pseudoholes with lamellar cleavage of their edge remain pseudoholes. Am J Ophthalmol 2013; 155: 733-742.
90. Reibaldi M, Parravano M, Varano M, Longo A, Avitabile T, Uva MG et al. Foveal microstructure and functional parameters in lamellar macular hole. Am J Ophthalmol 2012; 154: 974-980.
91. Lee CS, Koh HJ, Lim HT, Lee KS, Lee SC. Prognostic factors in vitrectomy for lamellar macular hole assessed by spectral-domain optical coherence tomography. Acta Ophthalmol 2012; 90: e597-e602.
92. Lee SJ, Jang SY, Moon D, Choi KS, Jung GY. Long-term surgical outcomes after vitrectomy for symptomatic lamellar macular holes. Retina 2012; 32: 1743-1748.
93. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 1971; 75: 813-820.
94. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991; 109: 654-659.
95. Wollensak G, Spoerl E, Grosse G, Wirbelauer C. Biomechanical significance of the human internal limiting lamina. Retina 2006; 26: 965-968. (Pubitemid 44547456)
96. Wu Y, Zhu W, Xu D, Li YH, Ba J, Zhang XL et al. Indocyanine green-assisted internal limiting membrane peeling in macular hole surgery: a meta-analysis. PLoS ONE 2013; 7(11): e48405.
97. Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A et al. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci 2011; 52: 1586-1592.
98. Alkabes M, Salinas C, Vitale L, Burés-Jelstrup A, Nucci P, Mateo C. En face optical coherence tomography of inner retinal defects after internal limiting membrane peeling for idiopathic macular hole. Invest Ophthalmol Vis Sci 2011; 52: 8349-8355.
99. Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1994; 101: 682-686. (Pubitemid 24113228)
100. PassemardM, Yakoubi Y, Muselier A, Hubert I, Guillaubey A, Bron AM et al. Long-term outcome of idiopathic macular hole surgery. Am J Ophthalmol 2010; 149: 120-126.
101. Kellner L,Wimpissinger B, Stolba U, BrannathW, Binder S. 25-gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised trial. Br J Ophthalmol 2007; 91: 945-948. (Pubitemid 47013110)
102. Nadal J, Delas B, Pinero A. Vitrectomy without face-down posturing for idiopathic macular holes. Retina 2012; 32: 918-921.
103. McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular traction syndrome. Ophthalmology 1994; 101: 1397-1402.
104. Massin P, Erginay A, Haouchine B, Paques M, Santiago PY, Than-Trong T et al. Results of surgery of vitreomacular traction syndrome. J Fr Ophthalmol 1997; 20: 539-547. (Pubitemid 27395855)
105. Rouhette H, Gastaud P. Idiopathic vitreomacular traction syndrome. vitrectomy results. J Fr Ophthalmol 2001; 24: 496-504. (Pubitemid 32531691)
106. Koerner F, Garweg J. Vitrectomy for macular pucker and vitreomacular traction syndrome. Doc Ophthalmol 1999; 97: 449-458.
107. Witkin AJ, Patron ME, Castro LC, Reichel E, Rogers AH, Baumal CR et al. Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome. Ophthalmic Surg Lasers Imag 2010; 41: 425-431.
108. Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U. High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up. Ophthalmology 2010; 117: 2010-2017.
109. Sonmez K, Capone Jr A, Trese MT, Williams GA. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina 2008; 28: 1207-1214.
110. Krishnan R, Tossounis C, Yang YF. 20-gauge and 23-gauge phacovitrectomy for idiopathic macular holes: comparison of complications and long-term outcomes. Eye 2013; 27: 72-77.
111. Jackson TL, Donachie PH, Sparrow JM, Johnston RL. United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 2013; 120: 629-634.
112. Spiteri Cornish K, Lois N, Scott N, Burr J, Cook J, Boachie C et al. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH). Cochrane Database Syst Rev 2013; 6: doi:10.1002/14651858.CD009306.pub2.
113. Tadayoni R, Gaudric A, Haouchine B, Massin P. Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol 2006; 90: 1239-1241. (Pubitemid 44621482)
114. Tadayoni R, Svorenova I, Erginay A, Gaudric A, Massin P. Decreased retinal sensitivity after internal limiting membrane peeling for macular hole surgery. Br J Ophthalmol 2012; 96: 1513-1516.
115. Pichi F, Lembo A, Morara M, Veronese C, Alkabes M, Nucci P et al. Early and late inner retinal changes after inner limiting membrane peeling. Int Ophthalmol 2013; e-pub ahead of print 18 July 2013 (PMID: 23864285).
116. Scupola A, Mastrocola A, Sasso P, Fasciani R, Montrone L, Falsini B et al. Assessment of retinal function before and after idiopathic macular hole surgery. Am J Ophthalmol 2013; 156: 132-139.
117. Hasegawa Y, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T et al. Equivalent tamponade by room air as compared with SF(6) after macular hole surgery. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1455-1459.
118. Eckardt C, Eckert T, Eckardt U, Porkert U, Gesser C. Macular hole surgery with air tamponade and optical coherence-based duration of face-down positioning. Retina 2008; 28: 1087-1096.
119. Rahman R, Madgula I, Khan K. Outcomes of sulphur hexafluoride (SF6) versus perfluoroethane (C2F6) gas tamponade for non-posturing macular hole surgery. Br J Ophthalmol 2012; 96: 185-188.
120. Kim SS, Smiddy WE, Feuer WJ, Shi W. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina 2008; 28: 1408-1415.
121. Lappas A, Foerster AM, Kirchhof B. Use of heavy silicone oil (Densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 2009; 87: 866-870.
122. Couvillion SS, Smiddy WE, Flynn Jr HW, Eifrig CW, Gregori G. Outcomes of surgery for idiopathic macular hole: a case-control study comparing silicone oil with gas tamponade. Ophthalmic Surg Lasers Imag 2005; 36: 365-371. (Pubitemid 41413190)
123. Lai JC, Stinnett SS, McCuen BW. Comparison of silicone oil versus gas tamponade in the treatment of idiopathic full-thickness macular hole. Ophthalmology 2003; 110: 1170-1174. (Pubitemid 36676650)
124. Solebo AL, Lange CAK, Bunce C, Bainbridge JW. Facedown positioning or posturing after macular hole surgery. Cochrane Database Syst Rev 2011; (Issue 12): Art. no: CD008228doi:10.1002/14651858.CD008228.pub2.
125. Muselier A, Dugas B, Burelle X, Passemard M, Hubert I, Mathieu B et al. Macular hole surgery and cataract extraction: combined vs. consecutive surgery. Am J Ophthalmol 2010; 150: 387-391.
126. Hirneiss C, Neubauer AS, Gass CA, Reiniger IW, Priglinger SG, Kampik A et al. Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol 2007; 91: 481-484. (Pubitemid 46623681)
127. Tadayoni R, Paques M, Massin P, Mouki-Benani S, Mikol J, Gaudric A. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology 2001; 108: 2279-2283. (Pubitemid 33096943)
128. Miura M, Elsner AE, Osako M, Iwasaki T, Okano T, UsuiM. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole. Retina 2003; 23: 561-563. (Pubitemid 37071978)
129. Moore JK, Kitchens JW, Smiddy WE, Mavrofrides EC, Gregorio G. Retinal breaks observed during pars plana vitrectomy. Am J Ophthalmol 2007; 144: 32-36.
130. Scartozzi R, Bessa AS, Gupta OP, Regillo CD. Intraoperative sclerotomy-related retinal breaks for macular surgery, 20- versus 25-gauge vitrectomy systems. Am J Ophthalmol 2007; 143: 155-156. (Pubitemid 44917805)
131. Ramkisson YD, Aslam SA, Shah SP,Wong SC, Sullivan PM. Risk of iatrogenic peripheral retinal breaks in 20-G pars plana vitrectomy. Ophthalmology 2010; 117: 1825-1830.
132. Tarantola RM, Tsui JY, Graff JM, Russell SR, Boldt HC, Folk JC et al. Intraoperative sclerotomy-related retinal breaks during 23-gauge pars plana vitrectomy. Retina 2013; 33: 136-142.
133. Tan HS, Mura M, de Smet MD. Iatrogenic retinal breaks in 25-gauge macular surgery. Am J Ophthalmol 2009; 148: 427-430.
134. Erlich R, Goh YW, Ahmad N, Polkinghorne P. Retinal breaks in small-gauge pars plana vitrectomy. Am J Ophthalmol 2012; 153: 868-872.
135. Lakhanpal RR, HumayunMS, De Juan Jr E, Lim JI, Chong LP, Chang TS et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 2005; 112: 817-824. (Pubitemid 40631500)
136. Byeon SH, Chu YK, Lee SC, Koh HJ, Kim SS, Kwon OW. Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery. Ophthalmologica 2006; 220: 259-265.
137. Rizzo S, Belting C, Genovesi-Ebert F, di Bartolo E. Incidence of retinal detachment after small-incision, sutureless pars plana vitrectomy compared with conventional 20-gauge vitrectomy in macular hole and epiretinal membrane surgery. Retina 2010; 30: 1065-1071.
138. Parolini B, Prigione G, Romanelli F, Sartore M, Pertile G. Postoperative complications and intraocular pressure in 943 consecutive cases of 23-gauge transconjunctival pars plana vitrectomy with 1-year follow-up. Retina 2010; 30: 107-111.
139. Rasouli M, Steed SM, Tennant MT, Rudnisky CJ, Hinz BJ, Greve MD et al. The 1-year incidence of rhegmatogenous retinal detachment post 23-gauge pars plana vitrectomy. Can J Ophthalmol 2012; 47: 262-263.
140. Gass CA, Haritoglou C, Messmer EM, Schaumberger M, Kampik A. Peripheral visual field defects after macular hole surgery: a complication with decreasing incidence. Br J Ophthalmol 2001; 85: 549-551. (Pubitemid 32397828)
141. Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 2002; 134: 661-666. (Pubitemid 35300383)
142. Wong SC, Clare G, Bunce C, Sullivan PM, Gregor ZJ, Ezra E. Cataract progression in macular hole cases: results with vitrectomy or with observation. J Cataract Refract Surg 2012; 38: 1176-1180.
143. Carvounis PE, Kopel AC, Kuhl DP, Heffez J, Pepple K, Holz ER. 25-gauge vitrectomy using sulphur hexafluoride and no prone positioning for repair of macular holes. Retina 2008; 28: 1188-1192.
144. Dugas B, Ouled-Moussa R, Lafontaine P-O, Guillaubey A, Berrod JP, Hubert I et al. Idiopathic epiretinal macular membrane and cataract extraction: combined versus consecutive surgery. Am J Ophthalmol 2010; 149: 302-306.
145. Lee JY, Kim KH, Shin KH, Han DH, Lee DY, Nam DH. Comparison of intraoperative complications of phacoemulsification between sequential and combined procedures of pars plana vitrectomy and cataract surgery. Retina 2012; 32: 2026-2033.
146. Ahfat FG, Yuen CHW, Groenewald CP. Phacoemulsification and intraocular lens implantation following pars plana vitrectomy: a prospective study. Eye 2003; 17: 16-20. (Pubitemid 36181832)
147. Lommatzsch A, Heimes B, Trieschmann M, Spital G, Pauleikhoff D. Long-term results after pars plana vitrectomy with 25 gauge technique. Ophthalmologe 2008; 105: 445-451.
148. Wu L, Berrocal MH, Arevalo JF, Carpentier C, Rodriguez FJ, Alezzandrini A et al. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina 2011; 31: 673-678.
149. Scott IU, Flynn Jr HW, Acar N, Dev S, Shaikh S, Mittra RA et al. Incidence of endopthalmitis after 20-gauge vs 23- gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2011; 249: 377-380.
150. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002; 240: 56-62. (Pubitemid 36075574)
151. Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J et al. Vitreoretinal morphology of plasmintreated human eyes. Am J Ophthalmol 2002; 133: 156-159. (Pubitemid 34076524)
152. Gandorfer A, Rohleder M, Sethi C, EckleD, Welge-Lussen U, Kampik A et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004; 45: 641-647. (Pubitemid 38140525)
153. de Smet MD, Valmaggia C, Zarranz-Ventura J,Willekens B. Microplasmin: ex vivo characterisation of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 2009; 50: 814-819.
154. Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005; 46: 3295-3299. (Pubitemid 44264318)
155. de SmetMD, Gandorfer A, Stalmans P, VeckeneerM, Feron E, Pakola S et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology 2009; 116: 1349-1355.
156. Benz MS, Packo KH, Gonzalez V, Pakola S, Bezner D, Haller JA et al. A placebo-controlled trial of microplasmin intravitreal injection to facilitate posterior vitreous detachment before vitrectomy. Ophthalmology 2010; 117: 791-797.
157. Stalmans P, Delaey C, de Smet M, van Dijkman E, Pakola S. Intravitreal injection of microplasmin for treatment of vitreomacular adhesion. Results of a prospective, randomized, sham-controlled Phase II trial (the MIVI-IIT trial). Retina 2010; 30: 1122-1127.
158. Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 2012; 367: 606-615.
159. Kuppermann B. on behalf of the MIVI-TRUST Study Group. Baseline features predictive of pharmacologic vitreomacular adhesion (VMA) resolution in the ocriplasmin MIVI-TRUST program. Congress of the European Society of Ophthalmology: Copenhagen, Denmark, June 8-11, 2013, Abstract FP-RET-092.
160. Huang J, Wen D, Wang Q. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 2012; 367: 2053; Author reply 2054.
161. Freund KB, Shah SA, Shah VP. Correlation of transient vision loss with outer retinal disruption following intravitreal oriplasmin. Eye 2013; 27: 773-774.
162. Chen W, Mo W, Sun K, Huang X, Zhang YL, Song HY. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy. Curr Eye Res 2009; 34: 1057-1064.
163. Fujii GY, De Juan Jr E, HumayunMS, Pieramici DJ, Chang TS, Awh C et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology 2002; 109: 1807-1812.
164. Ho LY, Garretson BR, Ranchod TM, Balasubramaniam M, Ruby AJ, Capone Jr A et al. Study of intraocular pressure after 23-gauge and 25-gauge pars plana vitrectomy randomized to fluid versus air fill. Retina 2011; 31: 1109-1117.
165. Wimpissinger B, Kellner L, Brannath W, Krepler K, Stolba U, Mihalics C et al. 23-Gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 2008; 92: 1483-1487.
166. Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology 2010; 117: 1851-1857.
167. Steel DH, Charles S. Vitrectomy fluidics. Ophthalmologica 2011; 226(Suppl 1): 27-35.